Loading...

NanoVibronix, Inc.

NAOVNASDAQ
Healthcare
Medical - Devices
$0.93
$-0.24(-20.75%)

NanoVibronix, Inc. (NAOV) Company Profile & Overview

Explore NanoVibronix, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

NanoVibronix, Inc. (NAOV) Company Profile & Overview

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.

SectorHealthcare
IndustryMedical - Devices
CEOBrian M. Murphy

Contact Information

914 233 3004
525 Executive Boulevard, Elmsford, NY, 10523

Company Facts

31 Employees
IPO DateMay 28, 2015
CountryUS
Actively Trading

Frequently Asked Questions

;